Table 2.
Patient demographic and clinical characteristics in the full sample
| Characteristic | Overall (N = 1542) |
|---|---|
| Mean ± SD age, years | 60.8 ± 16.5 |
| Male, n (%) | 949 (61.5) |
| White, n (%) | 1432 (92.9) |
| Mean ± SD CCI score | 2.3 ± 2.2 |
| Primary reason for hospitalization is treatment of MRSA cSSTI, n (%) | 1249 (81.0) |
| Timing of cSSTI index date, n (%) | |
| At hospital admission | 1282 (83.1) |
| 1–3 days after admission | 49 (3.2) |
| ≥4 days after admission | 211 (13.7) |
| Type of cSSTI, n (%) | |
| Surgical site infection or posttraumatic wound | 400 (25.9) |
| Major abscess | 271 (17.6) |
| Infected ulcer | 381 (24.7) |
| Deep or extensive cellulitis | 406 (26.3) |
| Other (including infected burn) | 84 (5.4) |
| cSSTI location, n (%) | |
| Head/skull/neck | 63 (4.1) |
| Torso/abdomen | 325 (21.1) |
| Upper extremity | 232 (15.0) |
| Lower extremity | 922 (59.8) |
| Sepsis, severe sepsis, or septic shock during cSSTI episode, n (%) | 265 (17.2) |
| Surgical procedures for treatment of cSSTI, n (%) | 597 (38.7) |
| Mean ± SD number of procedures among patients with any procedures | 0.4 ± 0.6 |
| Patient switched from IV-to-oral inpatient MRSA-active antibiotic treatment, n (%) | 197 (12.8) |
| Patient received MRSA-targeted therapy at discharge, n (%) | 514 (33.3) |
Abbreviations: CCI, Charlson comorbidity index; cSSTI, complicated skin and soft tissue infection; IV, intravenous; MRSA, methicillin-resistant Staphylococcus aureus; SD, standard deviation.